Suneel Gupta - Apr 26, 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Development Officer
Signature
/s/ Dinesh V. Patel, Ph.D., Attorney-in-Fact for Suneel Gupta
Stock symbol
PTGX
Transactions as of
Apr 26, 2022
Transactions value $
$295,200
Form type
4
Date filed
4/26/2022, 09:42 PM
Previous filing
Mar 2, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $295K +40K +51.57% $7.38 118K Apr 26, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -40K -36.36% $0.00 70K Apr 26, 2022 Common Stock 40K $7.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 554 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2022.
F2 The stock option vests over a four-year period, with 1/4th of the shares subject to the option vesting on January 15, 2020, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.

Remarks:

Exhibit 24 - Power of Attorney